New Hampshire HB1735 allows health care providers to conduct telehealth prescreenings for patients diagnosed with terminal or severe illnesses, and.

New Hampshire HB1735 modifies regulations to allow health care providers to conduct telehealth prescreenings for patients diagnosed with terminal or severe illnesses, regardless of the patient's location. It also permits the use of investigational drugs, biologics, and devices for patients with terminal or severe illnesses under the Right to Try Act. This act aims to promote access to potentially life-saving treatments and to incentivize clinical trials and development of new treatments.

New Hampshire HB1735 allows health care providers to conduct telehealth prescreenings for patients diagnosed with terminal or severe illnesses, and.

New Hampshire HB1735 modifies regulations to allow health care providers to conduct telehealth prescreenings for patients diagnosed with terminal or severe illnesses, regardless of the patient's location. It also permits the use of investigational drugs, biologics, and devices for patients with terminal or severe illnesses under the Right to Try Act. This act aims to promote access to potentially life-saving treatments and to incentivize clinical trials and development of new treatments.